HBK Investments’s Edwards Lifesciences EW Stock Holding History

HBK Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-141,300	Closed	-$5.31M	–	1018
2017 Q4	$5.31M	Buy	141,300 +57,000	+68%	+$2.09M	0.04%	253
2017 Q3	$3.07M	Buy	+84,300	New	+$3.22M	0.02%	359
2016 Q4	–	Sell	-77,076	Closed	-$3.1M	–	774
2016 Q3	$3.1M	Sell	77,076 -393,183	-84%	-$14.8M	0.03%	285
2016 Q2	$15.6M	Buy	470,259 +268,470	+133%	+$9.19M	0.12%	109
2016 Q1	$5.93M	Buy	201,789 +169,677	+528%	+$4.68M	0.06%	232
2015 Q4	$845K	Sell	32,112 -185,082	-85%	-$4.81M	0.01%	615
2015 Q3	$5.15M	Buy	+217,194	New	+$5.24M	0.05%	225
2015 Q2	–	Sell	-102,000	Closed	-$2.42M	–	983
2015 Q1	$2.42M	Sell	102,000 -375,000	-79%	-$8.41M	0.02%	367
2014 Q4	$10.1M	Buy	477,000 +162,600	+52%	+$3.27M	0.12%	126
2014 Q3	$5.35M	Buy	+314,400	New	+$4.96M	0.08%	198

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

HBK Investments's EW Position: Q1 2018 in Review

HBK Investments sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 141,300 shares — an estimated $5.31M sold.

HBK Investments first reported a position in EW in Q3 2014 and held it in 10 quarters. The position peaked at $15.6M in Q2 2016. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

HBK Investments reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
HBK Investments sold 141,300 Edwards Lifesciences shares in Q1 2018, an estimated $5.31M.
HBK Investments first reported a position in Edwards Lifesciences in Q3 2014 and held it in 10 quarters.
HBK Investments's Edwards Lifesciences position peaked at $15.6M in Q2 2016.
815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on HBK Investments's 13F filing for Q1 2018, filed 15 May 2018.